These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 20157312)

  • 1. Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility.
    O'Dushlaine C; Kenny E; Heron E; Donohoe G; Gill M; Morris D; ; Corvin A
    Mol Psychiatry; 2011 Mar; 16(3):286-92. PubMed ID: 20157312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive cross-disorder analyses of CNTNAP2 suggest it is unlikely to be a primary risk gene for psychiatric disorders.
    Toma C; Pierce KD; Shaw AD; Heath A; Mitchell PB; Schofield PR; Fullerton JM
    PLoS Genet; 2018 Dec; 14(12):e1007535. PubMed ID: 30586385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal cell adhesion genes: Key players in risk for schizophrenia, bipolar disorder and other neurodevelopmental brain disorders?
    Corvin AP
    Cell Adh Migr; 2010; 4(4):511-4. PubMed ID: 20574149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resequencing and association analysis of coding regions at twenty candidate genes suggest a role for rare risk variation at AKAP9 and protective variation at NRXN1 in schizophrenia susceptibility.
    Suárez-Rama JJ; Arrojo M; Sobrino B; Amigo J; Brenlla J; Agra S; Paz E; Brión M; Carracedo Á; Páramo M; Costas J
    J Psychiatr Res; 2015; 66-67():38-44. PubMed ID: 25943950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of shared risk loci and pathways for bipolar disorder and schizophrenia.
    Forstner AJ; Hecker J; Hofmann A; Maaser A; Reinbold CS; Mühleisen TW; Leber M; Strohmaier J; Degenhardt F; Treutlein J; Mattheisen M; Schumacher J; Streit F; Meier S; Herms S; Hoffmann P; Lacour A; Witt SH; Reif A; Müller-Myhsok B; Lucae S; Maier W; Schwarz M; Vedder H; Kammerer-Ciernioch J; Pfennig A; Bauer M; Hautzinger M; Moebus S; Schenk LM; Fischer SB; Sivalingam S; Czerski PM; Hauser J; Lissowska J; Szeszenia-Dabrowska N; Brennan P; McKay JD; Wright A; Mitchell PB; Fullerton JM; Schofield PR; Montgomery GW; Medland SE; Gordon SD; Martin NG; Krasnov V; Chuchalin A; Babadjanova G; Pantelejeva G; Abramova LI; Tiganov AS; Polonikov A; Khusnutdinova E; Alda M; Cruceanu C; Rouleau GA; Turecki G; Laprise C; Rivas F; Mayoral F; Kogevinas M; Grigoroiu-Serbanescu M; Becker T; Schulze TG; Rietschel M; Cichon S; Fier H; Nöthen MM
    PLoS One; 2017; 12(2):e0171595. PubMed ID: 28166306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel relationship for schizophrenia, bipolar and major depressive disorder Part 3: Evidence from chromosome 3 high density association screen.
    Chen X; Long F; Cai B; Chen X; Chen G
    J Comp Neurol; 2018 Jan; 526(1):59-79. PubMed ID: 28856687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control association study of NRXN1 polymorphisms with schizophrenia in Chinese Han population.
    Yue W; Yang Y; Zhang Y; Lu T; Hu X; Wang L; Ruan Y; Lv L; Zhang D
    Behav Brain Funct; 2011 Apr; 7():7. PubMed ID: 21477380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
    Cross-Disorder Group of the Psychiatric Genomics Consortium
    Lancet; 2013 Apr; 381(9875):1371-1379. PubMed ID: 23453885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of candidate single-nucleotide polymorphisms in NRXN1 related to antipsychotic treatment response in patients with schizophrenia.
    Jenkins A; Apud JA; Zhang F; Decot H; Weinberger DR; Law AJ
    Neuropsychopharmacology; 2014 Aug; 39(9):2170-8. PubMed ID: 24633560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further investigation of the association between rs7341475 and rs17746501 and schizophrenia.
    Ben-David E; Shifman S;
    Am J Med Genet B Neuropsychiatr Genet; 2010 Sep; 153B(6):1244-7. PubMed ID: 20468075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A hypothesis-driven pathway analysis reveals myelin-related pathways that contribute to the risk of schizophrenia and bipolar disorder.
    Yu H; Bi W; Liu C; Zhao Y; Zhang D; Yue W
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():140-5. PubMed ID: 24447946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A genome-wide meta-analysis identifies novel loci associated with schizophrenia and bipolar disorder.
    Wang KS; Liu XF; Aragam N
    Schizophr Res; 2010 Dec; 124(1-3):192-9. PubMed ID: 20889312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurexin-1 and frontal lobe white matter: an overlapping intermediate phenotype for schizophrenia and autism spectrum disorders.
    Voineskos AN; Lett TA; Lerch JP; Tiwari AK; Ameis SH; Rajji TK; Müller DJ; Mulsant BH; Kennedy JL
    PLoS One; 2011; 6(6):e20982. PubMed ID: 21687627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genetic variation of RELN expression in schizophrenia and bipolar disorder.
    Ovadia G; Shifman S
    PLoS One; 2011; 6(5):e19955. PubMed ID: 21603580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NCAM1 association study of bipolar disorder and schizophrenia: polymorphisms and alternatively spliced isoforms lead to similarities and differences.
    Atz ME; Rollins B; Vawter MP
    Psychiatr Genet; 2007 Apr; 17(2):55-67. PubMed ID: 17413444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mini-review: Update on the genetics of schizophrenia.
    Coelewij L; Curtis D
    Ann Hum Genet; 2018 Sep; 82(5):239-243. PubMed ID: 29923609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathway analyses implicate glial cells in schizophrenia.
    Duncan LE; Holmans PA; Lee PH; O'Dushlaine CT; Kirby AW; Smoller JW; Öngür D; Cohen BM
    PLoS One; 2014; 9(2):e89441. PubMed ID: 24586781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of pathways for bipolar disorder: a meta-analysis.
    Nurnberger JI; Koller DL; Jung J; Edenberg HJ; Foroud T; Guella I; Vawter MP; Kelsoe JR;
    JAMA Psychiatry; 2014 Jun; 71(6):657-64. PubMed ID: 24718920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association study between the neurexin-1 gene and tardive dyskinesia.
    Lanning R; Lett TA; Tiwari AK; Brandl EJ; de Luca V; Voineskos AN; Potkin SG; Lieberman JA; Meltzer HY; Müller DJ; Remington G; Kennedy JL; Zai CC
    Hum Psychopharmacol; 2017 Jan; 32(1):. PubMed ID: 28120489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurexin gene family variants as risk factors for autism spectrum disorder.
    Wang J; Gong J; Li L; Chen Y; Liu L; Gu H; Luo X; Hou F; Zhang J; Song R
    Autism Res; 2018 Jan; 11(1):37-43. PubMed ID: 29045040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.